This application is to renew the T32 ES-09250-30 training grant entitled, ?Environmental Carcinogenesis and Mutagenesis? (ECM) which has been under the direction of Dr. Stambrook since its inception in 1986. Dr. Alvaro Puga, the Co-PI, has been a mentor in the Program since early in its history and has served as Associate Director for the past five-year budget period, a role in which he will continue. The ECM training program initially focused exclusively on environmental carcinogenesis and mutagenesis as its title implied. Subsequently, the Program has evolved scientifically and conceptually. It grew to its current optimal size when the NIEHS directed that it merge with a smaller training program in toxicology. The Program became scientifically more diverse which has proven invaluable to the trainees. The ECM program makes every effort to retain this breadth of disciplines to enhance cross-fertilization of ideas and techniques between the trainees. Thus, the trainees are able to discuss cogently the impact of environmental exposures in terms of genetics, cell biology and toxicology and ultimately in the context of human disease, including cancer. To preserve this wide range of disciplines, the Program maintains a participating faculty of 26 who derive from 12 different departments/divisions from the University of Cincinnati College of Medicine (UCCOM) or the Cincinnati Children's Hospital Medical Center (CCHMC). There is a very close working relationship between the faculty of these two institutions, and the CCHMC faculty all have appointments in pediatrics at UCCOM. The financial support committed to the ECM from both institutions for recruitment and for other training-related expenses exemplifies this tight relationship and support for the ECM. The ECM continues to build on its past successes, with its graduates populating academic, regulatory and industry leadership positions. It also continues to fulfill a national need to train individuals in the impact of environmental exposure relating to biological, oncological and toxicological endpoints and human disease. Since its inception, the Program has emphasized recruitment of under-represented minorities, and has been successful in this endeavor. Institutionally, the Program brings together the research efforts of several laboratories to provide a common focus on exposure and environmental health, and facilitates collaborations between these laboratories. The ECM encourages trainees to engage in research that combines the expertise of several laboratories and institutional research cores. Our biweekly meetings where trainees alternatively present their own data or a topical paper reinforce these interactions. Pre-doctoral trainees all have the equivalent of an undergraduate major in a chemical, biological or physical science with superior academic achievements. Many have won awards and recognition while in the Program. We select postdoctoral candidates who hold the degrees of Ph.D., D.V.M. or M.D., based on proven academic accomplishments, and like predoctoral fellows, we select trainees from a national pool of applicants. This renewal application requests eight pre-doctoral and four postdoctoral positions, a size that we find optimal for the mission and goals of this Program.

Public Health Relevance

This training program trains predoctoral and postdoctoral fellows in multiple disciplines and state-of-the-art technologies. The intent is to elucidate biological mechanisms that form the basis of diseases, including cancer, that arise as a consequence of exposure to diverse environmental agents. The goal of this training program is to produce leaders in academia, the biotechnology and pharmaceutical industries and regulatory agencies who have the experience and knowledge to understand and make informed decisions in the environmental health sciences.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Institutional National Research Service Award (T32)
Project #
2T32ES007250-31
Application #
9936585
Study Section
Environmental Health Sciences Review Committee (EHS)
Program Officer
Shreffler, Carol A
Project Start
1988-07-01
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
31
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Genetics
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Meyer, Sara E; Muench, David E; Rogers, Andrew M et al. (2018) miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med 215:2115-2136
VonHandorf, Andrew; Sánchez-Martín, Francisco Javier; Biesiada, Jacek et al. (2018) Chromium disrupts chromatin organization and CTCF access to its cognate sites in promoters of differentially expressed genes. Epigenetics 13:363-375
Miesfeld, Joel B; Moon, Myung-Soon; Riesenberg, Amy N et al. (2018) Rbpj direct regulation of Atoh7 transcription in the embryonic mouse retina. Sci Rep 8:10195
Muench, David E; Ferchen, Kyle; Velu, Chinavenmeni S et al. (2018) SKI controls MDS-associated chronic TGF-? signaling, aberrant splicing, and stem cell fitness. Blood 132:e24-e34
Dwivedi, Pankaj; Muench, David E; Wagner, Michael et al. (2018) Time resolved quantitative phospho-tyrosine analysis reveals Bruton's Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors. Leukemia :
Hunt, Brian G; Wang, Yuan-Liang; Chen, Min-Shan et al. (2017) Maternal diethylhexyl phthalate exposure affects adiposity and insulin tolerance in offspring in a PCNA-dependent manner. Environ Res 159:588-594
Smith, Eric A; Kumar, Bhavna; Komurov, Kakajan et al. (2017) DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma. Oncotarget 8:23414-23426
Smith, Eric A; Gole, Boris; Willis, Nicholas A et al. (2017) DEK is required for homologous recombination repair of DNA breaks. Sci Rep 7:44662
Michel, Daniel R; Mun, Kyu-Shik; Ho, Chia-Chi et al. (2016) Cytoskeletal architecture and cell motility remain unperturbed in mouse embryonic fibroblasts from Plk3 knockout mice. Exp Biol Med (Maywood) 241:603-10
Lozada, Enerlyn M; Andrysik, Zdenek; Yin, Moying et al. (2016) Acetylation and deacetylation of Cdc25A constitutes a novel mechanism for modulating Cdc25A functions with implications for cancer. Oncotarget 7:20425-39

Showing the most recent 10 out of 124 publications